First Affiliated Hospital Xi'an Jiaotong University

This study tests whether adding thiotepa to the standard chemo drug melphalan before a stem cell transplant can lower the chance of cancer returning in people with multiple myeloma. It includes 204 adults aged 18-70 who have not achieved complete remission despite prior treatment…

This study tests whether giving a clot-busting drug (rhPro-UK) before a standard clot-removal procedure helps stroke patients recover better. About 820 adults with a large-vessel blockage will receive either the drug or a placebo within 4.5 to 24 hours of their first symptoms. Th…

This study tests whether adding a step to remove blood clots during a standard heart attack procedure helps prevent future heart problems. About 6,760 adults having a severe heart attack will be randomly assigned to get the standard procedure with or without clot removal. Researc…

This early study tests a new type of immune cell therapy (bispecific AbTCR-T cells) in 3 adults with B-cell lymphoma that has not responded to or returned after at least two prior treatments. The cells are designed to recognize and attack two cancer markers (CD19 and CD22) at onc…